Join Jeremy Docken, CEO of Kalderos, and Adam Fein, CEO of Drug Channels Institute, to learn about the 340B program's use of rebates, and how greater adoption of the 340B rebate process will benefit all stakeholders.
View the full webinar or download the slide decks below.
<span class="blog-button">Download webinar presentation</span>